RepPrep.ai is a purpose-built AI platform for medical sales teams, transforming physician, claims, and research data into actionable insights and pre-call plans within seconds. With seamless integration, customized datasets, and continuously updated information, RepPrep.ai equips organizations to optimize targeting, enhance ROI, and streamline sales effectiveness.
Regeneron
Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous FDA-approved treatments and product candidates in development. Visit www.Regeneron.com to learn more.
Raycision Medical Technology Co.,Ltd.
Raycision Medical Technology was founded by a team of scientists and engineers with entrepreneurial spirit. Nurtured within a research laboratory environment, our endeavors flourish through a steadfast commitment to innovation, collaboration, and the pursuit of excellence in craftsmanship. Raycision offers cutting-edge multimodality imaging technology and image-guided radiation platform for preclinical studies. Our patented RAYCISION image-guided radiation therapy (IGRT) system, tailored specifically for small animal radiotherapy, streamlines the entire process from tumor detection, treatment planning, dose calculation, treatment delivery and ultimately, to response assessment.
Quest Healthcare, A Division of Quest Products LLC
Quest Healthcare is a specialty healthcare company focused on improving patient comfort, protecting skin integrity, and supporting quality of life through clinically relevant, patient-centered solutions. We partner with WOC nurses, clinicians, and caregivers across acute care, long-term care, rehabilitation, home health, and hospice settings to address the real-world challenges of wound management, skin breakdown, and incontinence-associated complications. Our approach blends thoughtful product design with education and collaboration, helping care teams deliver consistent, compassionate care while supporting clinical best practices. A cornerstone of our portfolio is Alocane® Plus, a topical wound and skin care product designed to provide fast-acting comfort while supporting the healing environment. Alocane Plus combines OTC maximum-strength lidocaine with aloe vera and moisturizing agents to help relieve pain, burning, and irritation commonly associated with wounds, compromised skin, and periwound tissue. Its non-greasy, easy-to-apply formulation integrates smoothly into existing wound care protocols without interfering with dressings. WOC clinicians utilize Alocane Plus to enhance patient comfort, support adherence to care plans, and address pain-related barriers that can negatively impact healing and overall outcomes. Quest Healthcare also offers Doctor Butler’s®, a trusted brand dedicated to gentle, effective skin care solutions for patients experiencing incontinence. Doctor Butler’s Soothing Incontinence Spray is a touchless application used to calm irritated, inflamed skin resulting from repeated exposure to moisture, urine, and stool. The convenient formulation acts as a skin protectant to temporarily relieve chafed or cracked skin while providing additional moisture barrier properties. This formulation makes it especially beneficial for fragile or compromised skin. By helping to soothe discomfort and support the skin barrier, the spray plays a crucial role in prevention and management strategies for incontinence-associated dermatitis. Complementing the spray is Doctor Butler’s Cleansing Lotion, a rinse-free moisturizing cleanser designed for routine perineal care and sensitive skin. The lotion effectively removes contaminants while helping maintain the skin’s natural moisture balance, reducing reliance on harsh soaps and excessive wiping. Its gentle formulation supports skin integrity and dignity while promoting consistent, standardized hygiene practices across care settings. Used together, Doctor Butler’s products help clinicians establish reliable skin care routines that reduce breakdown risk and improve patient comfort. What sets Quest Healthcare apart is our commitment to clinical education and partnership. We recognize that effective wound and continence care extends beyond products alone. By working alongside WOC professionals, we aim to support evidence-informed practice, improve patient experiences, and reduce preventable skin complications. At WOCN, Quest Healthcare is proud to share solutions that prioritize comfort, integrity, and compassionate care—because protecting the skin means protecting the patient.
Quantum-Si
Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company’s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live. Learn more at quantum-si.com | Quantum-Si is redefining proteomic analysis by making single molecule protein analysis fast, simple, and accessible to every lab, everywhere. Powered by our core technology, Next-Gen Protein Sequencing™, Quantum-Si’s single-molecule platform enables kinetic measurements, revealing not just which proteins are present, but how they behave and interact within biological systems. By removing the complexity of traditional workflows like gels, Western blots, or specialized core facilities, Quantum-Si brings powerful, quantitative proteomic capabilities directly to the benchtop. It’s a new approach to protein analysis, one that provides both identification and quantitative understanding in a single platform with unparalleled resolution. With Quantum-Si, researchers gain deeper clarity into the molecular mechanisms that shape life, and the human condition. This advancement supports a new era of functional proteomics, accelerating discoveries across research, therapeutic development, and beyond.
Quanterix Corp
Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With approximately 6,000 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company®, adding multiplexed tissue imaging with single-cell resolution to its portfolio and 1,396 installed instruments. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics. Learn more at www.quanterix.com.
ProTrials Research, Inc.
ProTrials Research, Inc. is a full-service clinical research organization (CRO) founded in 1996 and headquartered in Silicon Valley, California. As a women-owned business, ProTrials partners with pharmaceutical, biotechnology, and medical device companies to deliver high-quality clinical development services across all phases of research, from early Phase I through Phase IV. With a global operational footprint, ProTrials provides comprehensive capabilities including project management, clinical operations, site management and monitoring, data management, quality assurance, and regulatory support. The company has successfully completed more than 775 clinical projects across 17,500+ sites and 210,000+ subjects worldwide. ProTrials offers deep therapeutic expertise in ophthalmology. Known for its quality-driven approach, experienced teams, and strong site relationships, ProTrials is recognized as a trusted partner committed to delivering efficient, flexible, and high-quality clinical tr
ProMed Pharma LLC
ProMed Pharma specializes in hot melt extrusion and injection molding of drug-loaded polymers, applying this expertise to the cGMP manufacture of ophthalmic dosage forms and drug-device combination products. We partner with both early-stage and established pharmaceutical companies, using robust and scalable processes to enable controlled release of active pharmaceutical ingredients (APIs) across a range of polymer systems. From early feasibility through clinical supply and commercial production, ProMed supports the development of controlled-release therapies for intravitreal and intracameral implants, punctal plugs, ocular rings, and related ophthalmic delivery systems. Our facilities are equipped to handle a broad spectrum of potent compounds, including prostaglandins, tyrosine kinase inhibitors (TKIs), antibiotics, and steroids. For more information, please visit www.promedpharmallc.com
PREMIER DENTAL PRODUCTS
Premier Dental® is dedicated to delivering Inspired Solutions for Daily Dentistry® worldwide. For over 100 years, dental professionals have trusted Premier for innovative, standard-setting products that improve procedures, practices, and patient outcomes. Inspired by the work clinicians do every day, we are committed to providing effective, efficient solutions.
PozeSCAF Discovery Solutions
PozeSCAF is a preclinical drug discovery company, that leverages an in-house generative AI-based discovery platform – AxDrug integrated with computational chemistry tools and synthetic chemistry lab to create best-in-class lead candidates for our clients.